PRVA· Health Care› Health Information Services

Privia Health Group, Inc.

Stage 4 · Declining · week 6

As of Oct 22, 2026, Privia Health Group is in Stage 4, the downtrend phase, now in week 6 (since Sep 16, 2026). It closed at $22.89, 18.6% below its 52-week high and above its 200-day average, which is falling.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. More about the company

$22.89

+1.85% today

$2.9B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PRVA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 16w

S4 26w

S2 23w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 3w → S3 1w → S4 16w → S1 3w → S4 26w → S1 10w → S4 6w → S1 1w → S2 23w → S3 13w → S4 7w → S1 4w → S2 11w → S3 11w → S4 6w → S1 9w → S2 8w → S3 3w → S4 5w current

Total tracked: 166 weeks across 19 stage runs.

PRVA among Health Information Services15th of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%
…15	PRVAPrivia Health Group, Inc.	Stage 4 · wk 6	45	+19.8%

vs 52W High

-18.6%

$19.10 lo$28.10 hi

18.6% below 52W high, ongoing decline

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 6

1w13w26w

Week 6, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

0.8%

200 DMA: $22.71 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.81x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+19.8%

-10.3%

-2.6%

YTD

-2.5%

-12.0%

Scan Membership

Breakout Watch

Latest: 2024-11-22

3 appearances in last 60 days. First seen: 2022-06-22.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 6 · Vol 0.81x

2026-10-21S4

Wk 6 · Vol 0.64x

2026-10-20S4

Wk 5 · Vol 0.67x

2026-10-19S4

Wk 5 · Vol 0.60x

2026-10-16S4

Wk 5 · Vol 0.94x

2026-10-15S4

Wk 5 · Vol 1.53x

2026-10-14S4

Wk 5 · Vol 1.00x

2026-10-13S4

Wk 4 · Vol 1.53x

2026-10-12S4

Wk 4 · Vol 1.11x

2026-10-09S4

Wk 4 · Vol 0.89x

2026-10-08S4

Wk 4 · Vol 1.25x

2026-10-07S4

Wk 4 · Vol 1.30x

Moving averages & range

50 DMA

$20.83

200 DMA

$22.71

52W High

$28.10

52W Low

$19.10

5D Low

$22.44

Resistance levels (recent highs)

20d High

$22.93

60d High

$23.96

120d High

$28.10

250d High

$28.10

Next resistance

+0.2%

to 20d High

P/E (TTM)

109.0

Forward 21.5

Earnings Growth (YoY)

+250.0%

Revenue +21.4%

ROE

+4.3%

Profit margin +1.2%

Dividend Yield

0.00%

P/B 3.7

Privia Health Group: quick answers

What stage is Privia Health Group in?

As of Oct 22, 2026, Privia Health Group (PRVA) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 16, 2026 and is in week 6. What the four stages mean

Is Privia Health Group in an uptrend?

No. Privia Health Group is in a Stage 4 downtrend. It trades 0.8% above its 200-day average, which is falling.

How far is Privia Health Group from its 52-week high?

Privia Health Group closed at $22.89 on Oct 22, 2026, 18.6% below its 52-week high of $28.10. Its 52-week low is $19.10.

How has Privia Health Group performed over the past year?

As of Oct 22, 2026, Privia Health Group is down 12.0% over the past year and down 2.5% so far in 2026.

Which sector and industry is Privia Health Group in?

Privia Health Group is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.